19.07. Lessons learned on academia-industry collaboration in bringing robotics to motor-impaired individuals

Robotics offers large potential to help individuals who lost motor functions, but the field still faces many challenges. This talk investigates successes and gaps in translating academic solutions to tangible benefits for users. Examples and lessons learned from tech transfer attempts will be given, ranging from high-end neurorehabilitation training robots to low-cost consumer products that mitigate the risk of falling in daily life

Heike Vallery works on minimalistic and unconventional concepts to support human gait and balance. Since November 2019, she also holds a honorary professorship at the Department for Rehabilitation Medicine at Erasmus MC in Rotterdam. Heike Vallery received nu- merous fellowships and awards, such as the 1st prize of the euRobotics Technology Transfer Award 2014, and recently an Alexander-von-Humboldt professorship, to re- turn to RWTH Aachen..

24.05. Identifying Principles of Motor Skill Learning to Improve Mobility during Neurological Rehabilitation

Motor skill acquisition is the basis of a broad class of rehabilitation interventions for people post-stroke, individuals with spinal cord injury, and people with Parkinson’s disease. Here, I will describe our recent work in which we 1) assess how energetic cost and dynamic balance interact to regulate the acquisition of novel walking patterns and 2) develop novel, VR-based approaches for enhancing skill acquisition during locomotor training.

He and his team in the Locomotor Control Lab at USC use experimental studies and computational models to understand how mobility is controlled in healthy individuals and individuals with neuromotor impairments such as stroke and Parkinson’s disease. Dr. Finley is also one of the founding directors of the USC SensoriMotor Assessment and Rehabilitation Training Center (SMART-VR Center). The Center’s mission is to be an interdisciplinary center of excellence harnessing innovative advances in virtual reality to improve motor and cognitive function across multiple clinical populations such as stroke, Alzheimer’s, Parkinson’s disease.

25.01. The German Medical Informatics Initiative – Collaboration towards secondary use of routine clinical data

The German Medical Informatics Initiative (MII) is a long-term funding program by the Federal Ministry of Education and Research to tap the wealth of routine clinical data gathered in the German hospital landscape. In a collaboration of four separately funded consortia, the MII tackles technical, semantic, legal and organizational challenges towards the secondary use of these data. In addition to establishing interoperable infrastructures and processes, each consortium executes clinical use cases to demonstrate their applicability and value. To enhance cross-consortial collaboration and intersectoral outreach, several broad use cases including sites from all consortia have been funded, as well as Digital Hubs for Advances in Research and Healthcare. The MII is currently in the final year of its development and networking phase, with an additional funding phase scheduled for 2023-2026 with a stronger focus on consolidation, outreach and broad use cases.

In this talk an overview will be given on the collaborative structures developed in the MII, major results and milestones achieved, and an outlook towards future MII perspectives

Prof. Dr. Thomas Ganslandt is a medical doctor. After studying human medicine, he worked in general surgery and medical informatics at University Hospital Münster from 1998-2003 and at Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen from 2003-2018. In 2017, Thomas Ganslandt received his habilitation at the Medical Faculty of the Friedrich-Alexander-Universität Erlangen-Nürnberg. He was appointed to the professorship for Medical Informatics at the Medical Faculty Mannheim (Ruprecht-Karls-University Heidelberg) in 2018. He was the Acting Director of the Heinrich-Lanz-Center for Digital Health at Mannheim University Medicine and headed the Department of Biomedical Informatics.
Since 2017 he is a speaker of the Interoperability Working Group of the German Medical Informatics Initiative and since 2020 a member of its National Steering Committee. Since 2018 he is a Board member of the TMF – Technology, Methods, and Infrastructure for Networked Medical Research.

In Erlangen he will continue his successful work in the MIRACUM consortium, now as new Co-PI from the Erlangen site. In addition, at Erlangen University Hospital, Professor Ganslandt takes over the position of Chief Medical Information Officer, where he will be driving strategic aspects of aligning clinical care, research and IT infrastructure.

30.11. Digital Health – Reengineering Sustainable Health Systems

Digital Technologies and Artificial Intelligence are driving fundamental transformations in Health Systems and Healthcare industries.

Trends, Opportunites and Challenges will be discussed

He holds dual academic appointments as chaired Professor for Digital Health – Personalized Medicine at the joint Digital Engineering Faculty of the HPI and University Potsdam, and as Professor of Medicine and Systems Pharmacology and Therapeutics at the Icahn School of Medicine at Mount Sinai, New York City, USA. From November 2015 to July 2017 Erwin Böttinger was the CEO of the Berlin Institute of Health (BHI) where he played a key role in shaping its forward-looking strategy for ‘Personalized Medicine – Advanced Therapies’. From 2007 to 2015 he was the founding director of the Charles Bronfman Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai in New York City, USA, and the principal architect of the Institute’s BioMe Biobank. Erwin Böttinger is a pioneer in groundbreaking implementations of personalized medicine and digital health in clinical practice.